These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19494439)

  • 1. Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental.
    Lloret A; Badía MC; Mora NJ; Pallardó FV; Alonso MD; Viña J
    J Alzheimers Dis; 2009; 17(1):143-9. PubMed ID: 19494439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
    Filip V; Kolibás E
    J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E.
    Fillenbaum GG; Kuchibhatla MN; Hanlon JT; Artz MB; Pieper CF; Schmader KE; Dysken MW; Gray SL
    Ann Pharmacother; 2005 Dec; 39(12):2009-14. PubMed ID: 16227448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men.
    Lu PH; Masterman DA; Mulnard R; Cotman C; Miller B; Yaffe K; Reback E; Porter V; Swerdloff R; Cummings JL
    Arch Neurol; 2006 Feb; 63(2):177-85. PubMed ID: 16344336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPA potentiator treatment of cognitive deficits in Alzheimer disease.
    Chappell AS; Gonzales C; Williams J; Witte MM; Mohs RC; Sperling R
    Neurology; 2007 Mar; 68(13):1008-12. PubMed ID: 17389305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of vascular comorbidities on the antioxidant defense system in Alzheimer's disease].
    Polidori MC; Stahl W; De Spirt S; Pientka L
    Dtsch Med Wochenschr; 2012 Feb; 137(7):305-8. PubMed ID: 22318842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
    Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
    Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
    Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
    Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular bases of the treatment of Alzheimer's disease with antioxidants: prevention of oxidative stress.
    Viña J; Lloret A; Ortí R; Alonso D
    Mol Aspects Med; 2004; 25(1-2):117-23. PubMed ID: 15051321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of oxidative stress biomarkers on cognitive decline.
    Revel F; Gilbert T; Roche S; Drai J; Blond E; Ecochard R; Bonnefoy M
    J Alzheimers Dis; 2015; 45(2):553-60. PubMed ID: 25589716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
    Song IU; Kim JS; Yoo JY; Song HJ; Lee KS
    Eur Neurol; 2008; 59(1-2):49-54. PubMed ID: 17917458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
    Tam LS; Li EK; Leung VY; Griffith JF; Benzie IF; Lim PL; Whitney B; Lee VW; Lee KK; Thomas GN; Tomlinson B
    J Rheumatol; 2005 Feb; 32(2):275-82. PubMed ID: 15693087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment.
    Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
    Free Radic Res; 2008 Feb; 42(2):162-70. PubMed ID: 18297609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of oxidative stress in diabetes mellitus during uncontrolled and controlled state and after vitamin E supplementation.
    Chugh SN; Kakkar R; Kalra S; Sharma A
    J Assoc Physicians India; 1999 Apr; 47(4):380-3. PubMed ID: 10778519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial.
    Scheltens P; Kamphuis PJ; Verhey FR; Olde Rikkert MG; Wurtman RJ; Wilkinson D; Twisk JW; Kurz A
    Alzheimers Dement; 2010 Jan; 6(1):1-10.e1. PubMed ID: 20129316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.